Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.15B Sell
40,825,470
-6,237,910
-13% -$166M 0.31% 59
2025
Q4
$1.17B Buy
47,063,380
+5,572,451
+13% +$141M 0.32% 65
2025
Q3
$1.1B Buy
41,490,929
+4,043,413
+11% +$99.8M 0.35% 57
2025
Q2
$948M Sell
37,447,516
-14,642,887
-28% -$341M 0.33% 62
2025
Q1
$1.27B Buy
52,090,403
+15,758,846
+43% +$412M 0.46% 43
2024
Q4
$976M Sell
36,331,557
-10,800,352
-23% -$293M 0.34% 58
2024
Q3
$1.38B Sell
47,131,909
-3,020,962
-6% -$88.1M 0.51% 39
2024
Q2
$1.39B Buy
50,152,871
+3,797,029
+8% +$105M 0.53% 31
2024
Q1
$1.19B Buy
46,355,842
+3,786,243
+9% +$105M 0.51% 31
2023
Q4
$1.25B Buy
42,569,599
+4,034,449
+10% +$122M 0.56% 27
2023
Q3
$1.24B Buy
38,535,150
+4,075,254
+12% +$144M 0.61% 23
2023
Q2
$1.26B Sell
34,459,896
-613,986
-2% -$23.9M 0.64% 23
2023
Q1
$1.46B Buy
35,073,882
+2,545,942
+8% +$110M 0.78% 18
2022
Q4
$1.55B Buy
32,527,940
+779,617
+2% +$37.4M 0.85% 19
2022
Q3
$1.4B Buy
31,748,323
+3,958,979
+14% +$192M 0.83% 17
2022
Q2
$1.43B Buy
27,789,344
+2,149,041
+8% +$110M 1.15% 8
2022
Q1
$1.41B Buy
25,640,303
+1,362,436
+6% +$70.7M 0.95% 11
2021
Q4
$1.35B Buy
24,277,867
+4,235,747
+21% +$210M 0.86% 11
2021
Q3
$862M Sell
20,042,120
-74,835
-0.4% -$3.32M 0.6% 26
2021
Q2
$788M Buy
+20,116,955
New +$782M 0.55% 32

Other funds holding PFE

Amundi's PFE Position: Q1 2026 in Review

Amundi reduced its Pfizer (PFE) stake by 13% in Q1 2026, selling an estimated $166M and leaving 40,825,470 shares worth $1.15B. The position accounts for 0.31% of the portfolio, ranked #59.

Amundi first reported a position in PFE in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.55B in Q4 2022. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Amundi held 40,825,470 shares of Pfizer worth $1.15B as of Q1 2026.
  • Amundi sold 6,237,910 Pfizer shares in Q1 2026, an estimated $166M.
  • Pfizer made up 0.31% of Amundi's portfolio in Q1 2026, its #59 holding.
  • Amundi first reported a position in Pfizer in Q2 2021 and has held it in 20 quarters since.
  • Amundi's Pfizer position peaked at $1.55B in Q4 2022.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.